Clinical trial
Rosiglitazone Plaque Study
NCT00123227 · Royal Brompton & Harefield NHS Foundation Trust, Other · Unknown status
Key facts
| NCT number | NCT00123227 |
|---|---|
| Title | Rosiglitazone Plaque Study |
| Official title | A Randomised, Double-Blind, Placebo-Controlled, Cardiovascular Magnetic Resonance (CMR) Study to Evaluate the Effect of Rosiglitazone on Carotid Atherosclerotic Plaques in Type 2 Diabetics With Vascular Disease or Hypertension |
| Lead sponsor | Royal Brompton & Harefield NHS Foundation Trust, Other |
| Collaborators | GlaxoSmithKline Industry CORDA, The Heart Charity |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2, Vascular Diseases, Hypertension |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 60 |
| Start date | Oct 1, 2002 |
| Completion | May 1, 2005 |
| First posted | Jul 22, 2005 |
| Last update posted | Aug 1, 2005 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: